Orgenesis Inc.
ORGS · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | -$14 |
| % Growth | 41.1% | 74.5% | 101% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $3 |
| Gross Profit | -$0 | -$1 | -$1 | -$17 |
| % Margin | -68.6% | -304.5% | -437.6% | 123.3% |
| R&D Expenses | $4 | $1 | $2 | $0 |
| G&A Expenses | $2 | $2 | $3 | $26 |
| SG&A Expenses | $2 | $2 | $6 | $26 |
| Sales & Mktg Exp. | $0 | $0 | $3 | $0 |
| Other Operating Expenses | $2 | $0 | $0 | $29 |
| Operating Expenses | $8 | $3 | $8 | $55 |
| Operating Income | -$8 | -$4 | -$9 | -$72 |
| % Margin | -2,419% | -1,653.7% | -6,297.9% | 528.9% |
| Other Income/Exp. Net | $18 | -$5 | -$1 | $27 |
| Pre-Tax Income | $9 | -$9 | -$10 | -$44 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | $9 | -$9 | -$10 | -$34 |
| % Margin | 2,628.2% | -3,619.5% | -6,925.5% | 252.9% |
| EPS | -0.19 | -0.23 | -0.29 | -2.09 |
| % Growth | 17.4% | 20.7% | 86.1% | – |
| EPS Diluted | -0.19 | -0.23 | -0.29 | -2.09 |
| Weighted Avg Shares Out | 47 | 39 | 33 | 3 |
| Weighted Avg Shares Out Dil | 47 | 39 | 33 | 3 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $0 | $0 |
| EBITDA | -$8 | -$8 | -$9 | -$44 |
| % Margin | -2,208.4% | -3,258.5% | -6,245.4% | 321.7% |